Efficacy of risankizumab in patients with moderate-to-severe plaque psoriasis by baseline demographics, disease characteristics and prior biologic therapy : an integrated analysis of the phase III UltIMMa-1 and UltIMMa-2 studies
-
Strober, Bruce (Central Connecticut Dermatology Research)
;
Menter, A. (Baylor Scott and White) ;
Leonardi, C. (Richmond Heights) ;
Gordon, Kenneth B (Medical College of Wisconsin) ;
Lambert, Jo (Ghent University) ;
Puig Sanz, Lluís (Institut d'Investigació Biomèdica Sant Pau) ;
Photowala, H. (AbbVie Inc.) ;
Longcore, M. (AbbVie Inc.) ;
Zhan, T. (AbbVie Inc.) ;
Foley, P. (St. Vincent's Hospital Melbourne) ;
Universitat Autònoma de Barcelona
visitante ::
identificación
Subscribirse to this discussion. You will then receive all new comments by email.
